Neumega Side Effects
Generic name: oprelvekin
Note: This document contains side effect information about oprelvekin. Some of the dosage forms listed on this page may not apply to the brand name Neumega.
Some side effects of Neumega may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to oprelvekin: subcutaneous powder for solution
Along with its needed effects, oprelvekin (the active ingredient contained in Neumega) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
The side effects listed below include only those that might be caused by oprelvekin. To find out about other side effects that may be caused by the cancer medicines you are also receiving, see the information about those medicines.
Check with your doctor as soon as possible if any of the following side effects occur while taking oprelvekin:More common
- Fast heartbeat
- fluid retention
- irregular heartbeat
- shortness of breath
- sore mouth or tongue
- swelling of feet or lower legs
- white patches in mouth and/or on tongue
- Bloody eye
- blurred vision
- severe redness and peeling of skin
- bloody urine
- blurred vision
- change in ability to see colors, especially blue or yellow
- cloudy urine
- decrease or increase in amount of urine
- difficulty swallowing
- discoloration of skin
- fainting or lightheadedness
- fast heartbeat
- feeling of pressure
- increased blood pressure
- increased thirst
- loss of appetite
- lower back/side pain
- puffiness or swelling of the eyelids or around the eyes face, lips or tongue
- shortness of breath
- skin rash
- stomach pain;
- tightness in chest
- troubled breathing
- unusual tiredness or weakness
- warmth at site
- weight gain
This medicine may also cause the following side effect that your doctor will watch for:More common
- Heart rhythm problems
Some side effects of oprelvekin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Red eyes
- Numbness or tingling of hands or feet
- skin discoloration
- skin rash at place of injection
For Healthcare Professionals
Applies to oprelvekin: subcutaneous powder for injection
Cardiovascular side effects reported in clinical trials by the patients treated with oprelvekin (the active ingredient contained in Neumega) have included tachycardia (20%), vasodilation (19%), palpitations (14%), syncope (13%), atrial fibrillation/flutter (12%).
Dermatologic side effects have included reports of rash in 25% of patients treated with oprelvekin (the active ingredient contained in Neumega) during clinical trials.
Gastrointestinal side effects reported during clinical trials have included reports of nausea and vomiting, mucositis, diarrhea, and oral moniliasis in 14% of patients treated with oprelvekin (the active ingredient contained in Neumega)
Nervous system side effects have included reports of dizziness and insomnia.
Respiratory side effects have included reports of dyspnea (48%), rhinitis, increase in cough, pharyngitis, and pleural effusions (10%).
Ocular side effects reported have included conjunctival infection and transient, mild visual blurring has occasionally been reported by patients treated with oprelvekin (the active ingredient contained in Neumega)
General side effects most frequently reported include edema (59%), neutropenic fever, headache, and fever.
Immunologic side effects reported have included the development of antibodies to oprelvekin (the active ingredient contained in Neumega) (1%). The clinical relevance of the presence of the antibodies is unknown. During the post-marketing setting, cases of allergic reactions with anaphylaxis have been reported.
More Neumega resources
- Neumega Prescribing Information (FDA)
- Neumega injectable Concise Consumer Information (Cerner Multum)
- Neumega Monograph (AHFS DI)
- Neumega MedFacts Consumer Leaflet (Wolters Kluwer)
- Neumega Advanced Consumer (Micromedex) - Includes Dosage Information
- Oprelvekin Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.